1. Home
  2. CLF vs VKTX Comparison

CLF vs VKTX Comparison

Compare CLF & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLF
  • VKTX
  • Stock Information
  • Founded
  • CLF 1847
  • VKTX 2012
  • Country
  • CLF United States
  • VKTX United States
  • Employees
  • CLF N/A
  • VKTX N/A
  • Industry
  • CLF Metal Mining
  • VKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLF Basic Materials
  • VKTX Health Care
  • Exchange
  • CLF Nasdaq
  • VKTX Nasdaq
  • Market Cap
  • CLF 3.2B
  • VKTX 2.8B
  • IPO Year
  • CLF N/A
  • VKTX 2015
  • Fundamental
  • Price
  • CLF $8.74
  • VKTX $28.14
  • Analyst Decision
  • CLF Buy
  • VKTX Buy
  • Analyst Count
  • CLF 9
  • VKTX 12
  • Target Price
  • CLF $12.13
  • VKTX $84.00
  • AVG Volume (30 Days)
  • CLF 35.5M
  • VKTX 3.9M
  • Earning Date
  • CLF 07-21-2025
  • VKTX 07-23-2025
  • Dividend Yield
  • CLF N/A
  • VKTX N/A
  • EPS Growth
  • CLF N/A
  • VKTX N/A
  • EPS
  • CLF N/A
  • VKTX N/A
  • Revenue
  • CLF $18,615,000,000.00
  • VKTX N/A
  • Revenue This Year
  • CLF $3.98
  • VKTX N/A
  • Revenue Next Year
  • CLF $6.14
  • VKTX N/A
  • P/E Ratio
  • CLF N/A
  • VKTX N/A
  • Revenue Growth
  • CLF N/A
  • VKTX N/A
  • 52 Week Low
  • CLF $5.63
  • VKTX $18.92
  • 52 Week High
  • CLF $16.47
  • VKTX $81.73
  • Technical
  • Relative Strength Index (RSI)
  • CLF 65.68
  • VKTX 55.39
  • Support Level
  • CLF $7.01
  • VKTX $25.80
  • Resistance Level
  • CLF $7.57
  • VKTX $28.80
  • Average True Range (ATR)
  • CLF 0.46
  • VKTX 1.65
  • MACD
  • CLF 0.18
  • VKTX 0.11
  • Stochastic Oscillator
  • CLF 93.46
  • VKTX 86.93

About CLF Cleveland-Cliffs Inc.

Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: